Ibogaine founder David Dardashti presents a new algorithm for methadone addiction treatment using synthetic methadone and preliminary ibogaine doses.

David Dardashti's Ibogaine presents a new algorithm for methadone addiction treatment, incorporating synthetic methadone and preliminary ibogaine doses. This alternative to Suboxone offers a steady, regulated treatment by uniformly distributing doses. Ibogaine founder David Dardashti is confident that this innovative approach will aid in transforming lives for those battling methadone addiction.